Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapyMehregan Babamohamadi, Jamshid Hadjati, Elham Faryadi et al.|Cell Death and Disease|2024Cited by 83
Recent advances in targeting LRRK2 for Parkinson’s disease treatmentMahsa Karami, Zhila Izadi, Pantea Majma Sanaye et al.|Journal of Translational Medicine|2025Cited by 14
NO: a key player in microbiome dynamics and cancer pathogenesisSeyedeh Kimia Jasemi, Zhila Izadi, Hossein Faridafshar et al.|Frontiers in Cellular and Infection Microbiology|2025Cited by 3
Navigating the Autophagy Maze: ATG and Their Impact on Neurodegenerative DiseasesRoshanak Amirian, Davood Rezazadeh, Zhila Izadi et al.|Molecular Neurobiology|2025Cited by 1